Suppr超能文献

草绿色链球菌是拓扑异构酶IV基因向肺炎链球菌进行水平转移的供体。

Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

作者信息

Balsalobre Luz, Ferrándiz María José, Liñares Josefina, Tubau Fe, de la Campa Adela G

机构信息

Unidad de Genética Bacteriana (Consejo Superior de Investigaciones Científicas), Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.

出版信息

Antimicrob Agents Chemother. 2003 Jul;47(7):2072-81. doi: 10.1128/AAC.47.7.2072-2081.2003.

Abstract

A total of 46 ciprofloxacin-resistant (Cip(r)) Streptococcus pneumoniae strains were isolated from 1991 to 2001 at the Hospital of Bellvitge. Five of these strains showed unexpectedly high rates of nucleotide variations in the quinolone resistance-determining regions (QRDRs) of their parC, parE, and gyrA genes. The nucleotide sequence of the full-length parC, parE, and gyrA genes of one of these isolates revealed a mosaic structure compatible with an interspecific recombination origin. Southern blot analysis and nucleotide sequence determinations showed the presence of an ant-like gene in the intergenic parE-parC regions of the S. pneumoniae Cip(r) isolates with high rates of variations in their parE and parC QRDRs. The ant-like gene was absent from typical S. pneumoniae strains, whereas it was present in the intergenic parE-parC regions of the viridans group streptococci (Streptococcus mitis and Streptococcus oralis). These results suggest that the viridans group streptococci are acting as donors in the horizontal transfer of fluoroquinolone resistance genes to S. pneumoniae.

摘要

1991年至2001年期间,在贝尔维奇医院共分离出46株耐环丙沙星的肺炎链球菌菌株(Cip(r))。其中5株菌株在其parC、parE和gyrA基因的喹诺酮耐药决定区(QRDRs)显示出意外高的核苷酸变异率。对其中一株分离株的全长parC、parE和gyrA基因进行核苷酸序列分析,发现其具有与种间重组起源相符的嵌合结构。Southern印迹分析和核苷酸序列测定表明,在parE和parC QRDRs变异率高的肺炎链球菌Cip(r)分离株的parE-parC基因间隔区存在一个类ant基因。典型肺炎链球菌菌株中不存在类ant基因,而在草绿色链球菌(缓症链球菌和口腔链球菌)的parE-parC基因间隔区存在该基因。这些结果表明,草绿色链球菌在氟喹诺酮耐药基因向肺炎链球菌的水平转移中充当供体。

相似文献

1
Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2003 Jul;47(7):2072-81. doi: 10.1128/AAC.47.7.2072-2081.2003.
2
Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
Antimicrob Agents Chemother. 2008 Mar;52(3):822-30. doi: 10.1128/AAC.00731-07. Epub 2007 Dec 26.
3
9
Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2000 Apr;44(4):840-7. doi: 10.1128/AAC.44.4.840-847.2000.
10
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1996 Oct;40(10):2321-6. doi: 10.1128/AAC.40.10.2321.

引用本文的文献

1
favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones.
mBio. 2024 Feb 14;15(2):e0282823. doi: 10.1128/mbio.02828-23. Epub 2024 Jan 9.
2
Convergent impact of vaccination and antibiotic pressures on pneumococcal populations.
Cell Chem Biol. 2024 Feb 15;31(2):195-206. doi: 10.1016/j.chembiol.2023.11.003. Epub 2023 Dec 4.
4
5
Role of PatAB Transporter in Efflux of Levofloxacin in .
Antibiotics (Basel). 2022 Dec 17;11(12):1837. doi: 10.3390/antibiotics11121837.
6
Competence shut-off by intracellular pheromone degradation in salivarius streptococci.
PLoS Genet. 2022 May 25;18(5):e1010198. doi: 10.1371/journal.pgen.1010198. eCollection 2022 May.
7
Antibiotic resistance: Time of synthesis in a post-genomic age.
Comput Struct Biotechnol J. 2021 May 21;19:3110-3124. doi: 10.1016/j.csbj.2021.05.034. eCollection 2021.
8
Tackling Multidrug Resistance in Streptococci - From Novel Biotherapeutic Strategies to Nanomedicines.
Front Microbiol. 2020 Oct 6;11:579916. doi: 10.3389/fmicb.2020.579916. eCollection 2020.
9
Relationships among streptococci from the mitis group, misidentified as Streptococcus pneumoniae.
Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):1865-1878. doi: 10.1007/s10096-020-03916-6. Epub 2020 May 14.
10
Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to .
Front Microbiol. 2017 Oct 26;8:2074. doi: 10.3389/fmicb.2017.02074. eCollection 2017.

本文引用的文献

1
Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan.
Antimicrob Agents Chemother. 2002 Oct;46(10):3311-5. doi: 10.1128/AAC.46.10.3311-3315.2002.
2
Mefloquine and new related compounds target the F(0) complex of the F(0)F(1) H(+)-ATPase of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2002 Jun;46(6):1680-7. doi: 10.1128/AAC.46.6.1680-1687.2002.
3
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
N Engl J Med. 2002 Mar 7;346(10):747-50. doi: 10.1056/NEJMoa012122.
4
MEGA2: molecular evolutionary genetics analysis software.
Bioinformatics. 2001 Dec;17(12):1244-5. doi: 10.1093/bioinformatics/17.12.1244.
6
Genome of the bacterium Streptococcus pneumoniae strain R6.
J Bacteriol. 2001 Oct;183(19):5709-17. doi: 10.1128/JB.183.19.5709-5717.2001.
7
Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy.
J Infect Dis. 2001 Sep 15;184(6):794-8. doi: 10.1086/323086. Epub 2001 Aug 9.
8
Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2001 Sep;45(9):2631-4. doi: 10.1128/AAC.45.9.2631-2634.2001.
9
Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.
Science. 2001 Jul 20;293(5529):498-506. doi: 10.1126/science.1061217.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验